ALEXIS SANTANGELO: Open Payments
NPI 1881078624 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 16 payments from 8 companies in 2025. Trend: 2023 $2,339 · 2024 $2,116 · 2025 $965
Food & beverage: $515Consulting: $450
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 2 | $500 |
| Merz Pharmaceuticals, LLC | 1 | $125 |
| Amneal Pharmaceuticals LLC | 4 | $82 |
| Medtronic, Inc. | 1 | $71 |
| ABBVIE INC. | 3 | $70 |
| ACADIA Pharmaceuticals Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
Products named: INBRIJA, CREXONT, PERCEPT PC BRAINSENSE, BOTOX, NUPLAZID, AUSTEDO XR, INGREZZA.
Industry payments across TX — which companies pay providers there.
